Start here if you're new
what it is
Radian insures mortgages, helps lenders manage credit risk, and gets paid when banks want extra protection on home loans.
how it gets paid
Last year Radian made $1.2B in revenue.
why it's growing
Revenue grew 298.3% last year. The quarter looked steady, not explosive. Revenue growth was modest, but EPS grew faster, which is what you want from a mature insurer priced at.
what just happened
Latest quarter revenue was $301M, up 3% vs. prior year, while EPS rose 14% to $1.12.
At a glance
B++ balance sheet — above average — nothing keeping you up at night
65/100 earnings predictability — reasonably predictable
8.8x trailing p/e — the market's not buying it — or you found a deal
3.1% dividend yield — cash in your pocket every quarter
8.7% return on capital — nothing to write home about
xvary composite: 60/100 — average
What they do
Radian insures mortgages, helps lenders manage credit risk, and gets paid when banks want extra protection on home loans.
This is a trust business. If you are a lender, you care less about marketing and more about who can still pay claims when housing gets ugly. Radian carries a B++ balance sheet grade, long-term debt is 34% of capital, and its price stability score is 80 out of 100. Balance sheet grade → ability to absorb losses → so what: customers stick with the insurer that looks built to survive the bad years.
How they make money
$1.2B
annual revenue · their business grew +298.3% last year
total revenue
$1.2B
+298.3%
The products that matter
insures mortgage defaults
Mortgage Insurance
$1.2B revenue · 48.7% net margin
it's the core business. On $1.2B in revenue, Radian kept 48.7 cents of every dollar as profit. That's why the stock still screens cheap on earnings.
cash engine
specialty insurance expansion
Inigo acquisition
closed feb 2026
this is the diversification bet. The deal closed in February 2026 and is supposed to reduce dependence on mortgage insurance, which has been shrinking over time.
new chapter
Key numbers
8.8x
trailing p/e
P/E → how many dollars you pay for one dollar of profit → so what: you are buying Radian cheaper than many financial stocks.
$1.2B
ttm revenue
That is the sales base supporting the dividend, buybacks, and earnings power.
3.1%
dividend yield
Yield → cash paid back to you each year → so what: you get paid while waiting for the market to care.
8.7%
return on capital
Return on capital → profit earned on money invested in the business → so what: this is solid, not magical.
Financial health
B++
strength
- balance sheet grade B++ — above average financial health
- risk rank 3 — safer than 50% of stocks
- price stability 80 / 100
- long-term debt $2.3B (34% of capital)
B++ — functional but not a standout on the balance sheet.
Total return vs. market
Return history isn't available for RDN right now.
source: institutional data · return history unavailable
What just happened
beat estimates
Latest quarter revenue was $301M, up 3% vs. prior year, while EPS rose 14% to $1.12.
The quarter looked steady, not explosive. Revenue growth was modest, but EPS grew faster, which is what you want from a mature insurer priced at 8.8x earnings.
$301M
revenue
$1.12
eps
n/a
n/a
the number that mattered
The key number was EPS up 14% to $1.12, because profit grew faster than revenue's 3% gain.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
the #1 risk is the mortgage insurance business shrinking faster than Inigo can diversify it.
high
Core revenue erosion
Q4 2025 revenue fell 18.4% from a year ago, and the longer history is worse: revenue has declined at a 3% annual rate over 14 years.
That is a direct threat to the "cheap but stable" thesis. If the cash engine is smaller next year too, the low multiple is justified.
high
Leadership turnover during integration
The president and CFO resigned in February 2026 while Radian was integrating the Inigo acquisition.
Execution risk goes up when the people steering the deal leave mid-turn. You do not want strategic pivots and finance turnover arriving together.
med
Acquisition thesis fails to translate into growth
Inigo closed in February 2026 and moves Radian into specialty insurance lines that are newer to this story than mortgage insurance.
If the deal adds complexity without stabilizing revenue, investors are left with the old problem plus a new one.
med
Moderate balance sheet, not a fortress
B++ balance sheet grade and $2.3B of long-term debt equal 34% of capital.
That balance sheet is workable, but it does not give you infinite room for mistakes if underwriting weakens or integration drags on.
Radian is not a "something for nothing" stock. You're buying a profitable insurer with a real moat in a core market, plus a real need to prove that revenue can stop sliding.
source: institutional data · regulatory filings · risk analysis
Pay attention to
calendar
next earnings report
Expected April 29, 2026. Consensus EPS is $1.20. More important than the EPS beat: whether revenue is still down from a year ago.
trend
post-Inigo revenue direction
The core question is simple: does the acquisition actually flatten the revenue slide, or does the decline just continue with more moving parts.
risk
management stability after the CFO exit
The February 2026 departure matters because capital allocation and acquisition integration now have less room for sloppiness.
metric
buybacks versus dividend support
Management said it may resume repurchases under a $750M authorization. That matters because cheap insurers often create value through capital return when growth is scarce.
Analyst rankings
earnings predictability
65 / 100
This is middling. In human-speak, analysts think the earnings stream is usable, but not clean enough to treat like a utility.
risk rank
3
Risk rank 3 means this is around the middle of the pack on safety. Not fragile. Not a bunker.
price stability
80 / 100
The stock price has been steadier than most. That tells you the market sees this as a value-and-income name, not a high-drama trade.
source: institutional data
Institutional activity
institutional ownership data for RDN is being compiled.
source: institutional data
Price targets
3-5 year target range
n/a
n/a
$36
current price
n/a
target midpoint · n/a from current
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive